Clinical chemistry and laboratory medicine, Vol. 58, no.4, p. 496-517 (2020) CLINICAL CHEMISTRY AND LABORATORY MEDICINE Clinical Chemistry and Laboratory Medicine, 58(4), 496-517. WALTER DE GRUYTER GMBH Atherosclerosis, Vol. 294, p. 46-61 (2020) Atherosclerosis, 294, 46-61. ELSEVIER IRELAND LTD Langlois, M R, Nordestgaard, B G, Langsted, A, Chapman, M J, Aakre, K M, Baum, H, Borén, J, Bruckert, E, Catapano, A, Cobbaert, C, Collinson, P, Descamps, O S, Duff, C J, von Eckardstein, A, Hammerer-Lercher, A, Kamstrup, P R, Kolovou, G, Kronenberg, F, Mora, S, Pulkki, K, Remaley, A T, Rifai, N, Ros, E, Stankovic, S, Stavljenic-Rukavina, A, Sypniewska, G, Watts, G F, Wiklund, O, Laitinen, P & European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative 2020, ' Quantifying atherogenic lipoproteins for lipid-lowering strategies : consensus-based recommendations from EAS and EFLM ', Clinical Chemistry and Laboratory Medicine, vol. 58, no. 4, pp. 496-517 . https://doi.org/10.1515/cclm-2019-1253